When recombinant IL-1β was injected into the lateral ventricles or directly into the brain parenchyma in the animal models, the levels of IL-1α and IL-1β significantly increased, which would result in ischemia or other causes of brain damage [28–30]. Here, IL1A is linked to ischemia.